企業技術シンポジウム
Corporate Tech Sympo
概要 Overview
昨年度に引き続き“企業技術シンポジウム”を実施する運びとなりました。昨年同様、“核酸医薬品開発の発展にプラスとなるような企業技術のNew Data”にこだわり、一般的な宣伝的プレゼンテーションではない発表を期待して募集いたします。
Since the establishment of our society, we have continuously held the Industry Symposium at our annual meetings. In the 8th Annual Meeting held in July 2023, we rebranded this event as the Industry Technology Symposium. This symposium is dedicated to presentations that focus on 'New Data of Industry Technologies that Contribute to the Advancement of Nucleic Acid Pharmaceuticals Development,' rather than general promotional presentations.
目的 Objective
年会各セッション（化学・生物・DDS・臨床・レギュラトリーサイエンス）でカテゴライズされにくいが、核酸医薬品開発に寄与しうる新たな技術・知見を参加者と共有することで、核酸医薬品開発の加速及び、学会参加者の技術バックグラウンドが底上げされること。
The annual meeting is structured into five sessions: Chemistry, Biology, DDS, Clinical, and Regulatory Science. However, we believe it is highly beneficial to share new technologies and insights that may not easily fit into these categories but can significantly contribute to the development of nucleic acid therapeutics. The acceleration of nucleic acid therapeutics development and the enhancement of the technical background of the conference participants are core objectives of our society. We anticipate that this symposium will serve as a platform for specialized and multifaceted discussions from an industry perspective.
対象技術・企業例 Target Technologies and Example Companies
- 有用な核酸創薬技術で立ち上がったスタートアップ、または新たなプラットフォームを提供する企業
- 創薬プロジェクトの進捗や新規データ
- プロセスケミストリー（合成・精製・脱塩・凍結乾燥など）の新たな進捗や工業化データの議論・共有化
- 分析技術（品質・薬効薬理・動態）の新たな技術進捗及び知見
- レギュラトリー、GMP、申請、特許出願などでの課題やソリューション、提案など
- 主なイメージを記載しましたが、内容は限定されません。
- 核酸医薬品開発の発展にプラスとなるような企業技術のNew Dataを含む発表を期待しております。
- Startups established with innovative nucleic acid drug discovery technologies or companies providing new platforms
- Progress and new data of drug discovery projects
- Discussion and sharing of new progress and industrialization data in process chemistry (synthesis, purification, desalting, lyophilization, etc.)
- New technological advancements and insights in analytical techniques (quality, pharmacodynamics, kinetics)
- Challenges, solutions, and proposals in regulatory, GMP, application, patent filing, etc.
- While the main themes are outlined, the content is not limited to these areas.
- We expect presentations that include new data of industry technologies that contribute to the advancement of nucleic acid therapeutics development.
内容 Content
1社15分、6演題を予定（質疑時間等、詳細は後日決定します）
Each company will be allocated 15 minutes for their presentation, with a total of 6 presentations planned. Details such as Q&A time will be decided and communicated at a later date.
演題募集 Call for Presentations
アプリケーションフォームに技術概要を記入してください。
Interested parties are requested to fill out the technology overview in the application form.
エントリー
2025年4月23日を目途にアプリケーションフォームを年会事務局に送付してください。
Please submit the completed application form to the annual meeting office by Wednesday, April 23, 2025.
日本核酸医薬学会第10回年会 企業技術シンポジウム準備担当 10th Annual Meeting of the Nucleic Acids Therapeutics Society of Japan
村田俊平（田辺三菱製薬）、長南具通（日産化学）、佐藤秀昭（ルクサナバイオテク）、釘宮啓（塩野義製薬）、高橋大輔（味の素）、小寺淳（日本触媒）
The Organizing Committee for the Industry Innovation Symposium at the 10th Annual Meeting of the Nucleic Acids Therapeutics Society of Japan
